Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
People with kidney transplants often develop bone disease. One reason for bone disease may be overactivity of a gland in the neck called the parathyroid gland. Overactivity of the parathyroid gland may be caused by lack of Vitamin D in the body. It has recently been discovered that many patients with kidney transplants have low Vitamin D levels. The investigators are examining the effects of doxercalciferol on parathyroid hormone levels, proteinuria and bone turnover markers in people who have had a kidney transplant.
Epistemonikos ID: 9453e74add67eddd9dfcf62166d80f4386235073
First added on: May 05, 2024